DiscoverAt the Intersection of Science and LawmRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando
mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

Update: 2021-09-03
Share

Description

For decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice President, Worldwide of Clinical Operations at Pfizer, spent her early bench science career working with mRNA technology and had a front row seat to the creation of the COVID-19 vaccine. DLA Piper’s Dr. Lisa Haile talks with Dr. Fernando about the study of mRNA and how COVID-19 catalyzed its advancement.

See omnystudio.com/listener for privacy information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

DLA Piper